title: Gelatin coating to stabilize the transfection ability of nucleic acid polyplexes.
abstract: Amphiphilic polymers are effective in complexing and delivering therapeutic nucleic acids, such as plasmid DNA (pDNA) and short interfering RNA (siRNA). However, long-term stability of the complexes is not desirable, as it may have an impact on the transfection efficiency in vivo. To develop a method to preserve complex stability we first showed that pDNA complexes formed with the amphiphilic polymer linoleic acid-substituted polyethylenimine (PEI-LA) and incubated at 37°C lost ~90% of their transfection efficiency after only 24h of complex formation. Polyethyleneglycol modification of complexes to control the increase in complex size and incubation in scaffolds used for implantation did not preserve the transfection ability of the complexes. Among a variety of approaches explored, gelatin coating of complexes was found to be the best at maintaining the original transfection efficiency. Mechanistic studies suggested that improved complex uptake, not size stability, was responsible for retention of the transfection efficiency. Similarly to the results with pDNA, gelatin coating also prevented the decreases in uptake and silencing efficiency of siRNA complexes observed following incubation at 37°C. Gelatin-stabilized complexes were, furthermore, effective in vivo and led to subcutaneous transgene expression with a low pDNA dose that was otherwise ineffective. We conclude that a simple gelatin coating approach offers an efficient means to preserve the transfection efficiency of polyplexes.
authors.affiliation: Department of Biomedical Engineering, Faculties of Medicine and Dentistry and Engineering, University of Alberta, Edmonton, Alberta, Canada T6G 2G6.
authors.forename: Laura
authors.initials: L
authors.lastname: Rose
authors.forename: Hamidreza Montazeri
authors.initials: HM
authors.lastname: Aliabadi
authors.forename: Hasan
authors.initials: H
authors.lastname: Uludağ
mesh_terms: D020099:Coated Materials, Biocompatible / Q000008:administration & dosage / Q000138:chemical synthesis*; D004355:Drug Stability; D005780:Gelatin / Q000737:chemistry*; D057809:HEK293 Cells; D006801:Humans; D008422:Materials Testing; D010957:Plasmids / Q000008:administration & dosage / Q000737:chemistry* / Q000235:genetics*; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000737:chemistry* / Q000235:genetics*; D014162:Transfection / Q000379:methods*
chemical_list: D020099:Coated Materials, Biocompatible; D034741:RNA, Small Interfering; D005780:Gelatin